MENU
ENTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Entera Bio (ENTX) Ownership - Who owns Entera Bio?
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
Minrav Building - Fifth Floor
Phone
+972 25327151
Employees
19
Web
https://www.enterabio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
90.9M
P/E Ratio
N/A
Total Cash
12.57M
Projected Growth
N/A
Total Debt
220K
Revenue
223K
Risk (Beta)
1.44
Dividend Yield
N/A
Total Cash/Share
0.28
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
ENTX
Capitalization
90.9M
P/E Ratio
N/A
Risk (Beta)
1.44
Dividend Yield
N/A
Total Cash
12.6M
Total Cash/Share
0.28
Total Debt
220K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
223K
ROE
N/A
Book Value
19.4M
P/B Ratio
4.69
Cash Flow
N/A
Earnings
-0.26
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
13.07
Current Revenue Per Employee
2100.00
Dividends Per Share - Security
N/A
EBITDA
-10.05M
Float
N/A
Float - Current
N/A
Gross Income Margin
0.00
Revenue To Assets
-63.39
Shares Held By Institutions
16.3M
Shares Outstanding - Current
45.5M
Total Liabilities
2.22M
Total Volume MTD
N/A
Value
-1
Gain YTD
-5.660
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of flu medicines
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Minrav Building - Fifth Floor
Phone
+972 25327151
Employees
19
Web
https://www.enterabio.com